✦ LIBER ✦

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

✍ Scribed by Afdhal, Nezam; Zeuzem, Stefan; Kwo, Paul; Chojkier, Mario; Gitlin, Norman; Puoti, Massimo; Romero-Gomez, Manuel; Zarski, Jean-Pierre; Agarwal, Kosh; Buggisch, Peter; Foster, Graham R.; Bräu, Norbert; Buti, Maria; Jacobson, Ira M.; Subramanian, G. Mani; Ding, Xiao; Mo, Hongmei; Yang, Jenny C.; Pang, Phillip S.; Symonds, William T.; McHutchison, John G.; Muir, Andrew J.; Mangia, Alessandra; Marcellin, Patrick

Book ID: 121827083
Publisher: Massachusetts Medical Society
Year: 2014
Tongue: English
Weight: 436 KB
Volume: 370
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa1402454

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ledipasvir and Sofosbuvir for Previously

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

✍ Afdhal, Nezam; Reddy, K. Rajender; Nelson, David R.; Lawitz, Eric; Gordon, Stuar 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 525 KB

Boceprevir for Untreated Chronic HCV Gen

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

✍ Poordad, Fred; McCone, Jonathan; Bacon, Bruce R.; Bruno, Savino; Manns, Michael 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 552 KB

764 Sofosbuvir/Ledipasvir With and Witho

764 Sofosbuvir/Ledipasvir With and Without Ribavirin for 8 Weeks Compared to Sofosbuvir/Ledipasvir for 12 Weeks in Treatment-Naive Non-Cirrhotic Genotype-1 HCV-Infected Patients: The Phase 3 Ion-3 Study

✍ Kowdley, Kris V.; Gordon, Stuart C.; Reddy, K. Rajender; Rossaro, Lorenzo; Berns 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 166 KB

O56 SOFOSBUVIR/LEDIPASVIR WITH AND WITHO

O56 SOFOSBUVIR/LEDIPASVIR WITH AND WITHOUT RIBAVIRIN FOR 8 WEEKS COMPARED TO SOFOSBUVIR/LEDIPASVIR FOR 12 WEEKS IN TREATMENT-NAÏVE NON-CIRRHOTIC GENOTYPE-1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-3 STUDY

✍ Kowdley, K.V.; Stuart, G.C.; Reddy, R.K.; Rossaro, L.; Bernstein, D.E.; An, D.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 172 KB

O14 USE OF SOFOSBUVIR/LEDIPASVIR FIXED D

O14 USE OF SOFOSBUVIR/LEDIPASVIR FIXED DOSE COMBINATION FOR TREATMENT OF HCV GENOTYPE-1 IN PATIENTS COINFECTED WITH HIV

✍ Osinusi, A.; Townsend, K.; Nelson, A.; Kohli, A.; Gross, C.; Polis, M.A.; Pang, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Ledipasvir and Sofosbuvir for 8 or 12 We

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

✍ Kowdley, Kris V.; Gordon, Stuart C.; Reddy, K. Rajender; Rossaro, Lorenzo; Berns 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 508 KB